Martina Magni
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
CAR T expansion and systemic inflammation: diverging impacts on large B-cell lymphoma therapy in the multicenter CART SIE study.
Journal: Haematologica
Published: February 12, 2025
Brexucabtagene autoleucel in-vivo expansion and BTKi refractoriness have a negative influence on progression-free survival in mantle cell lymphoma: Results from CART-SIE study.
Journal: British journal of haematology
Published: October 29, 2024
Axicabtagene ciloleucel treatment is more effective in primary mediastinal large B-cell lymphomas than in diffuse large B-cell lymphomas: the Italian CART-SIE study.
Journal: Leukemia
Published: November 07, 2023
Prognostic impact of pretreatment cell-free DNA concentration in newly diagnosed peripheral T-cell lymphomas.
Journal: British journal of haematology
Published: October 03, 2023
Assessing the Accuracy of the Azure Kinect for Telerehabilitation After Breast Cancer Surgery.
Journal: Studies in health technology and informatics
Published: May 12, 2023
Sex specific regulation of TSPY-Like 2 in the DNA damage response of cancer cells.
Journal: Cell death & disease
Published: October 17, 2022
Targeting the DNA Damage Response to Increase Anthracycline-Based Chemotherapy Cytotoxicity in T-Cell Lymphoma.
Journal: International journal of molecular sciences
Published: February 24, 2022
Phenotypic Composition of Commercial Anti-CD19 CAR T Cells Affects In Vivo Expansion and Disease Response in Patients with Large B-cell Lymphoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 17, 2022
T-cell immune response after mRNA SARS-CoV-2 vaccines is frequently detected also in the absence of seroconversion in patients with lymphoid malignancies.
Journal: British journal of haematology
Published: July 30, 2021
CDKN2A deletion is a frequent event associated with poor outcome in patients with peripheral T-cell lymphoma not otherwise specified (PTCL-NOS).
Journal: Haematologica
Published: September 10, 2020
Tyrosine kinase inhibition to improve anthracycline-based chemotherapy efficacy in T-cell lymphoma.
Journal: British journal of cancer
Published: May 07, 2019
Last Updated: 09/26/2026